WO2023219591A3 - Film-coated tablet containing linagliptin - Google Patents

Film-coated tablet containing linagliptin Download PDF

Info

Publication number
WO2023219591A3
WO2023219591A3 PCT/TR2023/050422 TR2023050422W WO2023219591A3 WO 2023219591 A3 WO2023219591 A3 WO 2023219591A3 TR 2023050422 W TR2023050422 W TR 2023050422W WO 2023219591 A3 WO2023219591 A3 WO 2023219591A3
Authority
WO
WIPO (PCT)
Prior art keywords
film
coated tablet
tablet containing
containing linagliptin
linagliptin
Prior art date
Application number
PCT/TR2023/050422
Other languages
French (fr)
Other versions
WO2023219591A2 (en
Inventor
Neyir Zeynep TASKENT
Muhammed Emre KARA
Demet ULKER
Isa ALBAYRAK
Original Assignee
Atabay Kimya Sanayi Ve Tic. A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atabay Kimya Sanayi Ve Tic. A.S. filed Critical Atabay Kimya Sanayi Ve Tic. A.S.
Publication of WO2023219591A2 publication Critical patent/WO2023219591A2/en
Publication of WO2023219591A3 publication Critical patent/WO2023219591A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to film-coated tablet compositions containing Linagliptin. Microcrystalline cellulose and lactose are used as fillers at a ratio of 1.50:1.00 to 5 1.00:1.00 (w/w) by weight.
PCT/TR2023/050422 2022-05-09 2023-05-08 Film-coated tablet containing linagliptin WO2023219591A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2022/007542A TR2022007542A2 (en) 2022-05-09 2022-05-09 FILM COATED TABLET WITH LINAGLIPTIN
TR2022/007542 2022-05-09

Publications (2)

Publication Number Publication Date
WO2023219591A2 WO2023219591A2 (en) 2023-11-16
WO2023219591A3 true WO2023219591A3 (en) 2023-12-28

Family

ID=85160941

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2023/050422 WO2023219591A2 (en) 2022-05-09 2023-05-08 Film-coated tablet containing linagliptin

Country Status (2)

Country Link
TR (1) TR2022007542A2 (en)
WO (1) WO2023219591A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014080384A1 (en) * 2012-11-26 2014-05-30 Ranbaxy Laboratories Limited Pharmaceutical composition of linagliptin
EP2848242A1 (en) * 2013-09-12 2015-03-18 Sanovel Ilac Sanayi ve Ticaret A.S. Orally disintegrating formulations of Linagliptin
US20190290588A1 (en) * 2018-03-26 2019-09-26 Hetero Labs Limited Stable bilayer tablet compositions
CN111407730A (en) * 2020-03-16 2020-07-14 杭州华东医药集团新药研究院有限公司 Pharmaceutical composition containing linagliptin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014080384A1 (en) * 2012-11-26 2014-05-30 Ranbaxy Laboratories Limited Pharmaceutical composition of linagliptin
EP2848242A1 (en) * 2013-09-12 2015-03-18 Sanovel Ilac Sanayi ve Ticaret A.S. Orally disintegrating formulations of Linagliptin
US20190290588A1 (en) * 2018-03-26 2019-09-26 Hetero Labs Limited Stable bilayer tablet compositions
CN111407730A (en) * 2020-03-16 2020-07-14 杭州华东医药集团新药研究院有限公司 Pharmaceutical composition containing linagliptin

Also Published As

Publication number Publication date
TR2022007542A2 (en) 2022-05-23
WO2023219591A2 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
EP1802588A1 (en) Substituted amino-pyrimidones and uses thereof
WO2022125616A8 (en) Dialkyl tryptamines and their therapeutic uses
MX2023000835A (en) Formulations of 19-nor c3,3- disubstituted c21-n-pyrazolyl steroid and methods of use thereof.
WO2009031644A1 (en) Antifungal pharmaceutical composition
WO2022240379A3 (en) A stable pharmaceutical composition comprising selexipag
WO2006059168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6β,7β;15β,l6β-BISMETHYLENE-17α-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Ϝ-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
WO2022032195A3 (en) Spatial sequencing
WO2023219591A3 (en) Film-coated tablet containing linagliptin
MX2021012392A (en) Compounds, compositions and methods.
WO2022043754A3 (en) Radiopharmaceutical and methods
WO2022031862A3 (en) Heteroaryl and heterocyclyl compounds
WO2012010944A3 (en) Multiple unit tablet composition
WO2008107746A3 (en) Tablet comprising microorganisms and a combination of excipients and the manufacture process thereof
WO2022032073A3 (en) Trpml modulators
MX2022015495A (en) Inhibitors of nek7 kinase.
KR101806262B1 (en) Water stable film-coating tablet comprising alginic acid and sodium carboxymethylcellulose
DK1150963T3 (en) Substituted 4-amino-2-aryl tetrahydroquinazolines, their preparation and use, and pharmaceutical compositions containing them
WO2024003612A3 (en) Compounds and processes for the synthesis of sphingomyelins
WO2023122801A3 (en) Saponin production in yeast
CA2565513A1 (en) Pharmaceutical compositions comprising zd6474
WO2022131880A3 (en) Pharmaceutically stable soft capsule comprising two or more different compositions
WO2021010814A3 (en) Compositions of film coatings for tablets with increased gloss, method for production thereof and application of same
WO2020210521A3 (en) Compositions and methods for increasing muscle mass and oxidative metabolism
WO2008047320A3 (en) Multiple unit tablet compositions of benzimidazole compounds
TR202007783A1 (en) TABLET COMPOSITION OF FESOTHERODY